Lexaria Bioscience Corp (LEXX)

SIC:
190 EAST WALTON PLACE CHICAGO, IL 60611

Lexaria Bioscience Corp.'s proprietary drug delivery technology, DehydraTECHâ„¢, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company's technology can be applied to many different ingestible product formats, including foods, beverages, oral suspensions, tablets, and capsules. DehydraTECH has repeatedly demonstrated since 2016 with cannabinoids and nicotine the ability to increase bio-absorption by up to 5-10x, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is planned to be further evaluated for orally administered bioactive molecules, including anti-virals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), and nicotine. Lexaria has licensed DehydraTECH to multiple companies including a world-leading tobacco producer for the development of smokeless, oral-based nicotine products and for use in industries that produce cannabinoid beverages, edibles, and oral products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 18 patents granted and approximately 60 patents pending worldwide.

View SEC Filings from LEXX instead.

View recent insider trading info

Funds Holding LEXX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LEXX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

REESE ALBERT L JR

  • Director
27,034 2022-05-24 4

BAXTER NICHOLAS W

  • Director
39,200 2022-03-08 1

MCKECHNIE WILLIAM EDWARD

  • Director
41,391 2022-03-08 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 22:15:03 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 21:45:04 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 21:15:04 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 20:45:04 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 20:15:05 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 19:45:03 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 19:15:05 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 18:45:03 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 18:15:04 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 17:45:04 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 17:15:05 UTC -4.3959 6.7159 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 16:45:04 UTC -4.3939 6.7139 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 16:15:04 UTC -4.3939 6.7139 15000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 15:45:04 UTC -4.3939 6.7139 10000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 15:15:05 UTC -4.3939 6.7139 10000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 14:45:04 UTC -4.3939 6.7139 10000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 14:15:05 UTC -4.3939 6.7139 9000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 13:45:04 UTC -4.3939 6.7139 9000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 13:15:04 UTC -4.3939 6.7139 9000
LEXARIA BIOSCIENCE CORP LEXX 2022-08-12 12:45:04 UTC -4.3939 6.7139 9000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund LEXX -1700.0 shares, $-5593.0 2022-03-31 N-PORT

Elevate your investments